๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-04-08

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 ) (NCT07526974)

A Phase 3, Randomized, Double-blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat.

๐ŸŸก Not Yet Recruiting Phase3 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Caliway Biopharmaceuticals Co., Ltd.

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

A phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal subcutaneous fat.

Who can join: Review the eligibility criteria below.

Location: Investigational Site 1 โ€” Encinitas, California

Age range: 18 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (14 Sites)

  • Investigational Site 1 โ€” Encinitas, California
  • Investigational site 2 โ€” Aventura, Florida
  • Investigational Site 3 โ€” Alpharetta, Georgia
  • Investigational Site 4 โ€” Hunt Valley, Maryland
  • Investigational site 5 โ€” Omaha, Nebraska
  • Investigational site 6 โ€” New York, New York
  • Investigational Site 7 โ€” Canal Winchester, Ohio
  • Investigational site 8 โ€” Nashville, Tennessee
  • Investigational site 9 โ€” Austin, Texas
  • Investigational Site 10 โ€” Arlington, Virginia
  • Investigational Site 11 โ€” Seattle, Washington
  • Investigational site 12 โ€” Melbourne, Victoria
  • Investigational Site 13 โ€” Vancouver, British Columbia
  • Investigational Site 14 โ€” Woodbridge, Ontario

๐Ÿ“ž Contact the Study Coordinator

Phone: +886-2-26971355

Email: CR@caliway.com.tw

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Subcutaneous Fat clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—